| Features: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Aloe vera — a medicinal succulent (Aloe barbadensis Miller) used as a complex botanical mixture whose clinically used preparations typically derive from (i) the inner leaf gel (polysaccharide-rich) and/or (ii) whole-leaf extracts containing anthraquinones. It is best classified as a botanical/natural product mixture (not a single agent). Common abbreviations include AV (Aloe vera). Key bioactives often discussed in oncology-adjacent literature include polysaccharides such as acemannan (immunomodulatory/wound-healing biomaterial profile) and anthraquinones such as aloe-emodin/emodin/aloin (more directly cytotoxic in vitro, but also linked to GI toxicity/carcinogenic hazard signals in certain whole-leaf preparations). Primary mechanisms (ranked):
Bioavailability / PK relevance: Aloe preparations are heterogeneous. High–molecular-weight gel polysaccharides (e.g., acemannan) have limited systemic bioavailability and are most relevant for local mucosal/skin exposure or immune-adjacent effects; anthraquinones are more systemically absorbable but undergo metabolism and are constrained by GI tolerance and safety concerns. “Decolorized/low-anthraquinone” products differ materially from nondecolorized whole-leaf extracts. In-vitro vs systemic exposure relevance: Many reported anticancer effects use crude extracts or isolated anthraquinones at concentrations that may exceed typical achievable systemic levels from oral supplements; supportive-care benefits (skin/mucosa) are more plausibly local exposure–driven. Clinical evidence status: Predominantly preclinical for direct anticancer activity. Human evidence is mainly supportive-care (e.g., radiation dermatitis and oral mucositis), with mixed RCT outcomes and heterogeneous formulations; there is no high-quality evidence establishing Aloe vera as a primary anticancer therapy. Aloe vera Therapeutic properties include: anti-microbial, anti-viral, anti-cancer, anti-oxidant, anti-inflammatory, skin protection, wound healing, and regulation of blood glucose and cholesterol.active constituents, such as aloe-emodin and acemannan. • Aloe vera extracts harbor antioxidant compounds that can scavenge free radicals, protecting cells from oxidative damage—a factor in aging and cancer development. Aloe vera’s blend of bioactive compounds offers a range of biological activities—including anti-inflammatory, antioxidant, immunomodulatory, and wound-healing effects—that have attracted interest for complementary roles in health maintenance and cancer supportive care. While it is not a primary anticancer agent, its potential to mitigate treatment side effects, enhance immune responses, and possibly contribute to chemoprevention makes it a subject of ongoing research. Aloe vera — mechanistic axes relevant to cancer and supportive care
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Source: |
| Type: |
| CDK1, (Cyclin-dependent kinase 1) same as p34 (cdc2) kinase activity Mitotic Gatekeeper, Essential Cell-Cycle Engine, and Therapeutic Vulnerability Cell cycle control to gene expression regulation and apoptosis, CDK1 is intimately involved in many cellular events that are vital for cell survival. CDK1 is a significant biomarker in various cancers, with its overexpression often correlating with aggressive tumor characteristics and poor prognosis. Targeting CDK1 may offer therapeutic potential, especially in cancers where its expression is linked to unfavorable outcomes. |
| 5362- | AV, | Anti-cancer effects of aloe-emodin: a systematic review |
| - | Review, | Var, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:28 Target#:382 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid